SEC Form 4 · accession 0001209191-15-011615
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Lawrence V Stein
Officer — See Remarks
Period of report
Feb 6, 2015
Accepted (ET)
Feb 10, 2015 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 6, 2015 | A | 19,319 | $0.00 | A | 23,511 | D | |
| Common Stock | Feb 6, 2015 | F | 10,837 | $118.75 | D | 12,674 | D | |
| Common Stock | holding | — | — | — | 341 | I | 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock relating to the 2012-2014 Long Term Incentive Plan and issued under the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).
Remarks
Executive Vice President, General Counsel and Corporate Secretary